Results 201 to 210 of about 31,304 (262)
Downregulation of adenosine and adenosine A1 receptor contributes to neuropathic pain in resiniferatoxin neuropathy. [PDF]
Kan HW +5 more
europepmc +1 more source
Adenosine A1 receptor antagonism prevents DSI in hippocampal CA1 pyramidal cells: PS077. [PDF]
Freire J, Rombo DM, Sebastião AM.
europepmc +1 more source
Synthesis of novel (benzimidazolyl)isoquinolinols and evaluation as adenosine A1 receptor tools. [PDF]
Singh S +8 more
europepmc +1 more source
Adenosine-A1 receptor agonist induced hyperalgesic priming type II. [PDF]
Araldi D, Ferrari LF, Levine JD.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Adenosine A1 receptors and erythropoietin production
American Journal of Physiology-Cell Physiology, 1993N6-cyclopentyladenosine (CPA), a selective adenosine A1 receptor agonist, in a concentration range of 10(-9) to 10(-7) M, produced a significant decrease in erythropoietin (EPO) levels in a human hepatocellular carcinoma (Hep G2) cell culture (medium levels of EPO, 91.81 +/- 1.61 and 94.36 +/- 0.97% of control, respectively) after 24 h incubation in a
T, Ohigashi, J, Brookins, J W, Fisher
openaire +2 more sources
Adenosine receptor modelling. A1/A2a selectivity
European Journal of Medicinal Chemistry, 2006Three-dimensional models of the A(1) and A(2a) adenosine receptors (AR) were constructed by means of a homology procedure, using bovine rhodopsin as a template. In order to validate the two models, a docking analysis of selective agonists was carried out.
TUCCINARDI, TIZIANO +4 more
openaire +3 more sources

